You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 6, June 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (52)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dementias
 •Alert me on articles by topic

Frontotemporal Lobar Degeneration

Demographic Characteristics of 353 Patients

Julene K. Johnson, PhD; Janine Diehl, MD; Mario F. Mendez, MD, PhD; John Neuhaus, PhD; Jill S. Shapira, RN, PhD; Mark Forman, MD, PhD; Dennis J. Chute, MD; Erik D. Roberson, MD, PhD; Catherine Pace-Savitsky, MA; Manuela Neumann, MD; Tiffany W. Chow, MD; Howard J. Rosen, MD; Hans Forstl, MD; Alexander Kurz, MD; Bruce L. Miller, MD

Arch Neurol. 2005;62:925-930.

Background  Until recently, frontotemporal lobar degeneration (FTLD) was considered a rare neurodegenerative disorder that was difficult to diagnose. The publication of consensus criteria for FTLD, however, prompted systematic studies. The criteria categorize FTLD into 3 subgroups: frontotemporal dementia, semantic dementia, and progressive nonfluent aphasia.

Objective  To compare demographic characteristics of patients in the 3 FTLD subgroups.

Design  We compared diagnostic breakdown, age at onset, sex, Mini-Mental State Examination score at first visit, education, and neuropathological diagnoses in a large sample of FTLD patients from 3 different university dementia clinics, including 2 neurologic clinics in the United States and 1 psychiatric clinic in Germany.

Results  The frontotemporal dementia subgroup represented approximately half of all FTLD diagnoses. Patients diagnosed as having frontotemporal dementia (mean age, 57.5 years) and semantic dementia (mean age, 59.3 years) had an earlier age at onset than patients diagnosed as having progressive nonfluent aphasia (mean age, 63.0 years). There were significantly more men diagnosed as having frontotemporal dementia (63.5%) and semantic dementia (66.7%) when compared with progressive nonfluent aphasia (39.1%) (P = .005 for frontotemporal dementia vs progressive nonfluent aphasia and P = .002 for semantic dementia vs progressive nonfluent aphasia). Generally, the demographic features and diagnostic categories of the patient populations across the 3 sites were comparable. There were 68 deaths and 37 autopsies. Frontotemporal lobar degeneration with ubiquitin-positive {tau}-negative inclusions (48.5%), dementia lacking distinctive histopathological features (18.2%), and Pick disease (15.2%) were the most common neuropathological diagnoses.

Conclusions  These findings show that cohorts of patients can be combined using new research criteria for FTLD and demonstrate striking demographic differences among FTLD subgroups. The sex and age-at-onset differences suggest that there may be biological differences among FTLD subgroups. In this sample, FTLD with ubiquitin-positive inclusions accounted for half of all neuropathological diagnoses.


Author Affiliations: Departments of Neurology (Drs Johnson, Roberson, Rosen, and Miller and Ms Pace-Savitsky) and Biostatistics (Dr Neuhaus) and Gladstone Institute of Neurological Disease (Dr Roberson), University of California, San Francisco; Technische Universität Munich, Munich, Germany (Drs Diehl, Forstl, and Kurz); Departments of Neurology (Drs Mendez and Shapira) and Pathology and Laboratory Medicine (Dr Chute), University of California, Los Angeles; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia (Dr Forman); Center for Neuropathology and Prion Research, Ludwig Maximilians University, Munich (Dr Neumann); and The Rotman Research Institute of Baycrest Centre for Geriatric Care, University of Toronto, Toronto, Ontario (Dr Chow).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.